Data and Information
A review of studies published in npj Digital Medicine found diagnostic and triage accuracy varied but was generally low, raising concerns about using symptom checkers as patient-facing tools.
HIMSS22
Technology can offer insights to users in clear and concise ways, according to Brian Robertson, VisiQuate's founder and CEO.
According to the World Health Organization, breast cancer survival rates vary significantly between different countries.
Insurance navigator Fair Square Medicare raises $15 million, AI-enabled prostate cancer care startup Avenda Health scores $10 million, and oncology clinical trial startup Trial Library emerges from stealth with $5 million.
Also: Decentralized clinical trial startup Curebase names vice president of clinical operations, and digital opioid use disorder-treatment company Ophelia hires a chief technology officer.
Formerly known as IDx, the company received FDA De Novo clearance in 2018 for its IDx-DR system used to detect diabetic retinopathy.
HIMSS22
Surfacing important patient data per condition can help clinicians improve care, according to Jay Anders, MD, chief medical officer at Medicomp Systems.
Also, scientists from the University of South Australia have developed tiny fibre sensors for remote patient monitoring.
The company also has pending approvals for the device in Australia and Thailand.
The layoffs represent 13% of the AI-backed genomic and clinical data company's workforce.